Target intelligence / Profile preview

GET4 antisense RNA 1 (GET4-AS1)

Target
GET4-AS1
Molecular classification
Other (Antisense long non-coding RNA, antisense lncRNA, natural antisense transcript)
01

Overview

GET4 antisense RNA 1 (GET4-AS1) is a long non-coding RNA (lncRNA) transcribed from the genomic region antisense to the GET4 gene[1]. Like other antisense lncRNAs, GET4-AS1 does not encode a protein but may exert regulatory effects on the expression of its sense gene (GET4) by mechanisms such as modulating RNA stability, transcriptional interference, or recruiting epigenetic modifiers[2][4][5][6]. Antisense lncRNAs can influence biological processes including cell proliferation, cell death, or responses to cellular stress, through interactions with sense mRNAs or chromatin complexes[2][4][5][6]. There is currently no direct evidence that GET4-AS1 is a receptor, enzyme, transporter, or therapeutic target, nor are there documented disease roles, drug interactions, or well-established safety concerns related specifically to GET4-AS1 as of this search. Its main classification is as a regulatory lncRNA molecule, fitting within the broader class of natural antisense transcripts that function in gene regulation rather than direct therapeutic targeting[1][3][4][5].

Other names
GET4-AS1
02

Biological functions

Regulation of gene expressionmodulation of mRNA stabilitypotential involvement in cellular stress response or gene regulatory networks
03

Disease associations

Other (potential as a biomarker or regulator in disease states, but no specific diseases strongly associated to date)

Beyond the preview

Go deeper on GET4 antisense RNA 1 (GET4-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GET4 antisense RNA 1 (GET4-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call